Health Care Up Slightly as Traders Switch to Offense -- Health-Care Roundup
31 October 2014 - 9:06PM
Dow Jones News
Drug makers and health insurers rose, but not as much as the
broad market, as traders rotated into more economically sensitive
areas. AbbVie rose after the drug maker boosted its earnings
projection for the year and posted higher sales, thanks to
continued strength with its rheumatoid-arthritis drug Humira.
Pfizer ticked up after brokerage UBS said the drug giant is poised
to improve its share performance, despite a "frustrating year."
Pfizer's pipeline is "improving" and deal activity could
"rejuvenate investor interest," the brokerage said, as reported
earlier.
-Rob Curran, rob.curran@dowjones.com